Practical recommendations for the management of diabetes in patients with COVID-19.
Lancet Diabetes Endocrinol. 2020 Apr 23. pii: S2213-8587(20)30152-2.
Endocrinology in the time of COVID-19: Management of Diabetes insipidus and Hyponatraemia.
Eur J Endocrinol. 2020 Apr 1.
COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next.
Metabolism. 2020 Apr 19:154245.
Endocrine and metabolic link to coronavirus infection.
Nat Rev Endocrinol. 2020 Apr 2.
Diabetes self-management amid COVID-19 pandemic.
Diabetes Metab Syndr. 2020 Apr 13;14(4):351-354.
Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infection with reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc).
Diabetes Metab Syndr. 2020 May – Jun;14(3):251-254.
Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. Diabetes Metab Syndr. 2020 May – Jun;14(3):241-246.
COVID‐19 and diabetes. Diabet Med. 2020 May;37(5):723-725.
COVID-19, diabetes mellitus and ACE2: The conundrum. Diabetes Res Clin Pract. 2020 Mar 29;162:108132.
Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metab Res Rev. 2020 Mar 31:e33213321.
Our Response to COVID-19 as Endocrinologists and Diabetologists. J Clin Endocrinol Metab. 2020 May 1;105(5). pii: dgaa148
Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis. Arch Acad Emerg Med. 2020 Mar 24;8(1):e35. eCollection 2020.
Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020 May-Jun;14(3):211-212.
COVID-19 and diabetes: Can DPP4 inhibition play a role?. Diabetes Res Clin Pract. 2020 Mar 26;162:108125.
COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract. 2020 Apr 9;162:108142.
Diabetes is a risk factor for the progression and prognosis of COVID-19.
Diabetes Metab Res Rev. 2020 Mar 31:e3319.